Proceedings of the 2023 Santa Fe bone symposium: Progress and controversies in the management of patients with skeletal diseases

IF 1.7 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM
E. Michael Lewiecki , Teresita Bellido , John P. Bilezikian , Jacques P. Brown , Azeez Farooki , Christopher S. Kovacs , Brendan Lee , William D. Leslie , Michael R. McClung , Mark L. Prasarn , Deborah E. Sellmeyer
{"title":"Proceedings of the 2023 Santa Fe bone symposium: Progress and controversies in the management of patients with skeletal diseases","authors":"E. Michael Lewiecki ,&nbsp;Teresita Bellido ,&nbsp;John P. Bilezikian ,&nbsp;Jacques P. Brown ,&nbsp;Azeez Farooki ,&nbsp;Christopher S. Kovacs ,&nbsp;Brendan Lee ,&nbsp;William D. Leslie ,&nbsp;Michael R. McClung ,&nbsp;Mark L. Prasarn ,&nbsp;Deborah E. Sellmeyer","doi":"10.1016/j.jocd.2023.101432","DOIUrl":null,"url":null,"abstract":"<div><p>The Santa Fe Bone Symposium (SFBS) held its 23rd annual event on August 5-6, 2023, in Santa Fe, New Mexico, USA. Attendees participated in-person and remotely, representing many states and countries. The program included plenary presentations, panel discussions, satellite symposia, a Project ECHO workshop, and a session on healthcare policy and reimbursement for fracture liaison programs. A broad range of topics were addressed, including transitions of osteoporosis treatments over a lifetime; controversies in vitamin D; update on Official Positions of the International Society for Clinical Densitometry; spine surgery and bone health; clinical applications of bone turnover markers; basic bone biology for clinicians; premenopausal-, pregnancy-, and lactation-associated osteoporosis; cancer treatment induced bone loss in patients with breast cancer and prostate cancer; genetic testing for skeletal diseases; and an update on nutrition and bone health. There were also sessions on rare bone diseases, including managing patients with hypophosphatasia; treatment of X-linked hypophosphatemia; and assessment and treatment of patients with hypoparathyroidism. There were oral presentations of abstracts by endocrinology fellows selected from those who participated in the Santa Fe Fellows Workshop on Metabolic Bone Diseases, held the 2 days prior to the SFBS. These proceedings of the 2023 SFBS present the clinical highlights and insights generated from many formal and informal discussions in Santa Fe.</p></div>","PeriodicalId":50240,"journal":{"name":"Journal of Clinical Densitometry","volume":"26 4","pages":"Article 101432"},"PeriodicalIF":1.7000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1094695023000823/pdfft?md5=0e263a5fd19d230046f06c0a41287d18&pid=1-s2.0-S1094695023000823-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Densitometry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1094695023000823","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

The Santa Fe Bone Symposium (SFBS) held its 23rd annual event on August 5-6, 2023, in Santa Fe, New Mexico, USA. Attendees participated in-person and remotely, representing many states and countries. The program included plenary presentations, panel discussions, satellite symposia, a Project ECHO workshop, and a session on healthcare policy and reimbursement for fracture liaison programs. A broad range of topics were addressed, including transitions of osteoporosis treatments over a lifetime; controversies in vitamin D; update on Official Positions of the International Society for Clinical Densitometry; spine surgery and bone health; clinical applications of bone turnover markers; basic bone biology for clinicians; premenopausal-, pregnancy-, and lactation-associated osteoporosis; cancer treatment induced bone loss in patients with breast cancer and prostate cancer; genetic testing for skeletal diseases; and an update on nutrition and bone health. There were also sessions on rare bone diseases, including managing patients with hypophosphatasia; treatment of X-linked hypophosphatemia; and assessment and treatment of patients with hypoparathyroidism. There were oral presentations of abstracts by endocrinology fellows selected from those who participated in the Santa Fe Fellows Workshop on Metabolic Bone Diseases, held the 2 days prior to the SFBS. These proceedings of the 2023 SFBS present the clinical highlights and insights generated from many formal and informal discussions in Santa Fe.

2023年圣达菲骨骼研讨会论文集:骨骼疾病患者管理的进展和争议。
圣达菲骨研讨会(SFBS)于2023年8月5日至6日在美国新墨西哥州圣达菲举行了第23届年度活动。与会者代表许多州和国家亲自和远程参加。该项目包括全体演讲、小组讨论、卫星研讨会、ECHO项目研讨会以及关于医疗政策和骨折联络项目报销的会议。讨论了广泛的主题,包括骨质疏松症治疗在一生中的转变;维生素D争议;国际临床密度测定学会官方立场的最新情况;脊柱外科和骨骼健康;骨转换标志物的临床应用;临床医生的基础骨生物学;绝经前、妊娠期和哺乳期相关的骨质疏松症;癌症治疗导致癌症和癌症患者骨丢失;骨骼疾病基因检测;以及营养和骨骼健康方面的最新情况。也有关于罕见骨病的会议,包括管理低磷酸盐血症患者;X连锁低磷血症的治疗;以及甲状旁腺功能减退症患者的评估和治疗。内分泌研究员从参加SFBS前两天举行的Santa Fe研究员代谢性骨病研讨会的人中挑选了一些人,他们对摘要进行了口头陈述。2023年SFBS的这些会议记录展示了圣达菲许多正式和非正式讨论中产生的临床亮点和见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Densitometry
Journal of Clinical Densitometry 医学-内分泌学与代谢
CiteScore
4.90
自引率
8.00%
发文量
92
审稿时长
90 days
期刊介绍: The Journal is committed to serving ISCD''s mission - the education of heterogenous physician specialties and technologists who are involved in the clinical assessment of skeletal health. The focus of JCD is bone mass measurement, including epidemiology of bone mass, how drugs and diseases alter bone mass, new techniques and quality assurance in bone mass imaging technologies, and bone mass health/economics. Combining high quality research and review articles with sound, practice-oriented advice, JCD meets the diverse diagnostic and management needs of radiologists, endocrinologists, nephrologists, rheumatologists, gynecologists, family physicians, internists, and technologists whose patients require diagnostic clinical densitometry for therapeutic management.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信